Follow us:
+91 44 6746 8080 info@caplinsteriles.net
Menu
  • Home
  • About Us
    • Our Subsidiaries
    • Strength
    • Milestones
    • Board of Directors
    • Plant Leadership Team
    • Partnership
    • Gallery
  • News
  • Caplin Cares
  • Governance
    • Policy
      • Quality Policy
      • Environmental Policy
      • Code Of Conduct & Business Ethics
      • Data Protection And Privacy Policy
      • Environment, Health & Safety Policy
      • Equal Opportunity Policy
      • Human Rights Policy
      • Nomination And Remuneration Policy
      • Whistle Blower Policy (Vigil Mechanism)
    • Annual Return
    • Notice
  • Sustainability
    • CSR Activities
      • CSR Policy
      • Composition of CSR Committee
      • CSR Annual Action Plan for FY 2025–26
  • Careers
  • Contact

Caplin point announces FDA approval for ketrolac tromethamine injection 30mg/ml

August 7, 2020
| No Comments
20.09.2017Download
Categories: News

Post navigation

← Caplin point gets EIR for USFDA for sterile injectable site.
Caplin Steriles signs license & supply agreement with baxter healthcare corporation. →
About Us

Caplin Steriles Limited, a subsidiary of fast growing pharmaceutical company Caplin Point Laboratories Ltd, specifically targeted towards regulated markets for Injectables and Ophthalmics.

USEFUL LINKS
  • Home
  • About Us
    • Our Subsidiaries
    • Strength
    • Milestones
    • Board of Directors
    • Plant Leadership Team
    • Partnership
    • Gallery
  • News
  • Caplin Cares
  • Governance
    • Policy
      • Quality Policy
      • Environmental Policy
      • Code Of Conduct & Business Ethics
      • Data Protection And Privacy Policy
      • Environment, Health & Safety Policy
      • Equal Opportunity Policy
      • Human Rights Policy
      • Nomination And Remuneration Policy
      • Whistle Blower Policy (Vigil Mechanism)
    • Annual Return
    • Notice
  • Sustainability
    • CSR Activities
      • CSR Policy
      • Composition of CSR Committee
      • CSR Annual Action Plan for FY 2025–26
  • Careers
  • Contact
Latest Posts
CAPLIN STERILES GETS USFDA APPROVAL FOR METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION January 27, 2026
CAPLIN ACQUIRES 10 APPROVED ANDAs INJECTION AND OPTHALMIC PRODUCTS January 1, 2026
CAPLIN STERILES GETS USFDA APPROVAL FOR LINEZOLID INJECTION, INFUSION BAGS December 9, 2025
CAPLIN STERILES GETS USFDA APPROVAL FOR ACETAMINOPHEN INJECTION, INFUSION BAGS December 8, 2025
Get in touch

+91 44 2496 8000

info@caplinsteriles.net

Caplin Steriles Ltd.
1st Floor, Ashvich Towers,
No 3, Developed Plots Industrial Estate,
Perungudi, Chennai 600096.
Tamil Nadu,
India.

© 2026 Caplin Steriles Ltd . All Rights Reserved
Powered by Ashvich Infotek Pvt Ltd.